Elan: 2009

Elan Drug Technologies

Research &
Development

Investor Relations

Elan News: 2009

2nd July 2009

Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment

11th June 2009

Elan Announces Date of 2009 Annual General Meeting and Changes in Board of Directors

3rd June 2009

Elan to Present at Goldman Sachs 30th Annual Global Healthcare Conference

31st May 2009

Subset Data from Two Randomized Phase 3 Trials Show TYSABRI® Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNFa Therapy

29th May 2009

Renee P. Tannenbaum, Pharm.D. Joins Elan as Executive Vice President and Chief Commercial Officer

12th May 2009

Elan Announces Change in Board of Directors

28th April 2009

MRI Data Showing TYSABRI® Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology

23rd April 2009

Elan and Transition Therapeutics Receive Key Patent for Alzheimer's Disease Treatment with ELND005

22nd April 2009

Elan Reports First Quarter 2009 Financial Results

9th April 2009

Elan Announces Webcast of First Quarter 2009 Financial Results

2nd April 2009

Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols

30th March 2009

Elan Announces Filing of Annual Report for Year Ended December 31, 2008

12th March 2009

Elan to Present at Cowen and Company 29th Annual Health Care Conference

25th February 2009

Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process

10th February 2009

Elan Reports Fourth Quarter and Full-Year 2008 Results

9th February 2009

MS Patients Treated with TYSABRI® Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology

13th January 2009

Elan to Review Strategic Business Alternatives

13th January 2009

Elan Clarifies Duration of Bapineuzumab Phase 3 Trials

12th January 2009

Elan Announces Webcast of Fourth Quarter and Full Year 2008 Financial Results

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use